Back
CI DoubleLine Total Rtn Bd US$ ETF C$H Vs. Dyne Therapeutics Industry Stock Comparison
Sell
25
CDLB.TO
CI DoubleLine Total Rtn Bd US$ ETF C$H
Last Price:
16.75
Seasonality Move:
1.32%
Sell
46
DYN
Dyne Therapeutics
Last Price:
30.40
Seasonality Move:
38.02%
Sell
25
CI DoubleLine Total Rtn Bd US$ ETF C$H (CDLB.TO)
is a Sell
Is CI DoubleLine Total Rtn Bd US$ ETF C$H a Buy, Sell or Hold?
- The current CI DoubleLine Total Rtn Bd US$ ETF C$H [CDLB.TO] share price is $16.75. The Score for CDLB.TO is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- CDLB.TO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Dyne Therapeutics (DYN)
is a Sell
Is Dyne Therapeutics a Buy, Sell or Hold?
- The current Dyne Therapeutics [DYN] share price is $30.31. The Score for DYN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- DYN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CDLB.TO Stock Price Chart
What is CI DoubleLine Total Rtn Bd US$ ETF C$H's stock price today?
-
The CI DoubleLine Total Rtn Bd US$ ETF C$H share price today is $16.75
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CDLB.TO is experiencing slight buying pressure.
DYN Stock Price Chart
What is Dyne Therapeutics's stock price today?
-
The Dyne Therapeutics share price today is $30.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing selling pressure, which indicates risk of future bearish movement.
CDLB.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 6.37 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.74 - 17.08) | Sell |
Bollinger Bands (100): | (16.81 - 17.29) | Sell |
DYN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.91 | Sell |
Relative Strength Index (14 RSI): | 47.11 | Sell |
Chaikin Money Flow: | -1019710 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.92 - 33.44) | Sell |
Bollinger Bands (100): | (31.39 - 42.57) | Sell |
CDLB.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.75 | Sell |
20-day SMA: | 16.86 | Sell |
50-day SMA: | 17.11 | Sell |
200-day SMA: | 16.84 | Sell |
8-day EMA: | 16.76 | Sell |
20-day EMA: | 16.86 | Sell |
50-day EMA: | 16.99 | Sell |
200-day EMA: | 16.9 | Sell |
DYN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.77 | Buy |
20-day SMA: | 30.55 | Sell |
50-day SMA: | 32.55 | Sell |
200-day SMA: | 32.11 | Sell |
8-day EMA: | 30.26 | Buy |
20-day EMA: | 30.69 | Sell |
50-day EMA: | 32.85 | Sell |
200-day EMA: | 30.82 | Sell |
CI DoubleLine Total Rtn Bd US$ ETF C$H Earnings Growth & CDLB.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Dyne Therapeutics Earnings Growth & DYN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.10 per share.
CI DoubleLine Total Rtn Bd US$ ETF C$H Technical Analysis
Oct 31 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Dyne Therapeutics Technical Analysis
Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |